{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-25-051816","form_type":"8-K","ticker":"EPC","cik":"0001096752","company_name":"EDGEWELL PERSONAL CARE Co","filed_at":"2025-11-13T23:59:59+00:00","discovered_at":"2026-05-14T18:02:38.787422+00:00","generated_at":"2026-05-16T20:07:59.101285+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"confidence":"high","headline":"Edgewell Q4 net sales +3.8% to $537M; FY GAAP EPS $0.53, adj. $2.52; sells Feminine Care for $340M","bullets":["Q4 net sales $537.2M (+3.8% reported, +2.5% organic); FY net sales $2,223.5M (-1.3% both reported and organic).","GAAP diluted EPS $(0.66) for Q4, $0.53 for FY; adjusted EPS $0.68 for Q4, $2.52 for FY.","Board declared $0.15/share quarterly dividend and authorized new $100M share repurchase program.","Definitive agreement to sell Feminine Care business to Essity for $340 million; proceeds expected to reduce leverage.","Ended Q4 with $225.7M cash; net debt leverage ratio of 3.9x."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-25-051816","json":"https://secwatch.observer/filing/0001628280-25-051816.json","markdown":"https://secwatch.observer/filing/0001628280-25-051816.md","text":"https://secwatch.observer/filing/0001628280-25-051816.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1096752/000162828025051816/0001628280-25-051816-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1096752/000162828025051816/epc-20251113.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T20:07:59.101285+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}